Cerezyme fda approval?

When did FDA approve Cerezyme (imiglucerase)?

Cerezyme (imiglucerase) received FDA approval on May 7, 1994. [1]

What does Cerezyme treat?

Cerezyme is an enzyme replacement therapy used for Gaucher disease. [1]

How can I verify the FDA approval details?

You can confirm the approval date and product information through the FDA’s Drugs@FDA database for Cerezyme (imiglucerase). [1]

What if I meant a different “Cerezyme” approval (labeling vs. later updates)?

The FDA approval date above refers to the initial approval. If you’re looking for later label expansions, supplement approvals, or changes (for example, new indications or dosing language), the Drugs@FDA entry will list the relevant regulatory history tied to that product. [1]

Sources

1. FDA Drugs@FDA: Cerezyme (imiglucerase)